Drawing for PHARMVAC

USPTO serial 79335073

PHARMVAC

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MORRIS, KRISTINA KLOIBER
Law office
TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with PHARMVAC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
042Design and development of virtual reality software; scientific and technological services; scientific laboratory services; protein analysis; development of devices for protein analysis; design of devices intended for protein analysis; database design and development; scientific research conducted using databases; molecular analysis; development of devices for molecular analysis; development of computer software for big data processing; technical consultancy relating to the analysis of data for biotechnological applications; technical consultancy relating to the development of software for biotechnological applications; biotechnological research; biochemical analysis; software as a service [SaaS]; providing paas [platform as a service]; providing computer software technical support services based on artificial intelligence in the field of new drug development; drug discovery services; research in the field of pharmacogenetics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; development of pharmaceutical preparations and medicines; consultancy relating to pharmaceutical research and development; clinical testing of medicines; hosting computer sites [web sites] including medical information; design of medical diagnostic apparatus and instruments; computer programming services for remote data management of medical diagnostic instruments; providing computer software technical support services in the field of medical diagnostics; research of medical products; consultancy in the field of testing, inspection, research of medical products; research and development of computer software platforms in the field of artificial intelligence; development of software for artificial intelligence services; conducting clinical trials for others [scientific research]; updating and maintenance of computer software; new drug development services through computer modelling method; leasing of simulation programs for computers; chemical analysisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 27, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 4, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 4, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 27, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Aug 9, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 9, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jul 3, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 3, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 3, 2023ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 9, 2023RFNTREFUSAL PROCESSED BY IB—
Dec 17, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 17, 2022RFRRREFUSAL PROCESSED BY MPU—
Oct 5, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 4, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 21, 2022DOCKASSIGNED TO EXAMINER—
Mar 11, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 7, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 3, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance